Urology · Houston, TX
NPI
1699769935
Since 2005
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
6560 Fannin St Ste 1440
Houston, TX, 77030
Phone (713) 790-9700
Groups this clinician bills Medicare through
Medicare paid, 2024
$376K
21,982 services
Medicare patients, 2024
1,080
Average age 76
Drug cost, 2024
$1.2M
3,916 prescriptions
Company payments, 2025
$8,531
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A Sutton was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,400 times for 13 patients. In total Mark A Sutton billed 21,982 services in 114 codes, and Medicare paid $376K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-27.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,400 | 13 | $0.10 | $137 |
| 51798 Ultrasound - Nonspecific | Office | 1,224 | 917 | $7.81 | $9,560 |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 840 | 13 | $44.68 | $38K |
| 36415 Venipuncture Blood Collection | Office | 809 | 659 | $8.38 | $6,782 |
| 81003 Clinical Chemistry | Office | 724 | 591 | $2.19 | $1,589 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 721 | 156 | $48.05 | $35K |
| 99214 Office E&M - Established | Office | 621 | 513 | $88.05 | $55K |
| 99213 Office E&M - Established | Office | 594 | 513 | $59.76 | $35K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 285 | 115 | $37.82 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 277 | 259 | $11.39 | $3,155 |
| 99204 Office E&M - New | Office | 99 | 99 | $122.92 | $12K |
| 99443 Telephone Services | Office | 92 | 80 | $89.76 | $8,258 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 53 | 53 | $49.51 | $2,624 |
| 99212 Office E&M - Established | Office | 50 | 32 | $41.03 | $2,051 |
| 96372 Injection Administration | Office | 43 | 14 | $9.49 | $408 |
By year: 2022 $384K for 21,136 services; 2023 $393K for 25,854 services; 2024 $376K for 21,982 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 809 | 659 | $8.38 | $6,782 |
| 81003 Clinical Chemistry | 724 | 591 | $2.19 | $1,589 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark A Sutton prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,025 prescriptions and refills. In total Mark A Sutton wrote 3,916 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,025 | 2,989 | 359 | $23K |
| Finasteride Generic | 508 | 1,498 | 173 | $8,107 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 179 | 188 | 128 | $755 |
| Gemtesa Vibegron | 176 | 316 | 58 | $151K |
| Myrbetriq Mirabegron | 152 | 325 | 51 | $143K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 145 | 145 | 90 | $900 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 136 | 146 | 88 | $2,154 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 132 | 336 | 52 | $3,315 |
| Potassium Citrate Er Potassium Citrate | 102 | 276 | 33 | $19K |
| Ciprofloxacin Hcl Generic | 94 | 94 | 52 | $564 |
| Testosterone Cypionate Generic | 86 | 173 | 28 | $5,450 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 74 | 197 | 35 | $3,335 |
| Testosterone Generic | 72 | 78 | 20 | $7,818 |
| Dutasteride Generic | 60 | 180 | 21 | $2,398 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 58 | 168 | 18 | $1,642 |
Brand drugs: - claims; generic drugs: 3,427 claims; opioid claims: 87.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark A Sutton $8,531 ($8,531 in general payments such as food, travel and fees) from 29 companies. The largest payer was HMU Consumables, LLC with $5,143.
| Company | Payments | Amount |
|---|---|---|
| HMU Consumables, LLC | 2 | $5,143 |
| Biotissue Holdings Inc. | 17 | $921 |
| Astellas Pharma US Inc 4503.T | 6 | $272 |
| Sumitomo Pharma America, Inc. 4506.T | 36 | $265 |
| Medtronic, Inc. MDT | 5 | $236 |
| Pfizer Inc. PFE | 7 | $229 |
| Boston Scientific Corporation BSX | 7 | $190 |
| Dendreon Pharmaceuticals LLC | 5 | $164 |
| Antares Pharma, Inc. | 20 | $142 |
| Ferring Pharmaceuticals Inc. | 5 | $116 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.